Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 52 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 195 | 8,404−6.2%/yr | −6.2%/yr | 3.81.2× | 4% | 9,180 in 2030+1.5%/yr |
| Lumbar fusion | 196 | 8,171+0.1%/yr | +0.1%/yr | 3.71.2× | 4% | 9,840 in 2030+3.2%/yr |
| Cervical fusion & disc arthroplasty | 91 | 4,236−3.4%/yr | −3.4%/yr | 1.91.1× | 3% | 4,580 in 2030+1.3%/yr |
| Kyphoplasty & vertebroplasty | 43 | 3,866−5.3%/yr | −5.3%/yr | 1.81.0× | 26% | 3,550 in 2030−1.4%/yr |
| SI joint fusion | 20 | 1,201+17%/yr | +17%/yr | 0.51.7× | 59% | 2,330 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 1,025 | 283,370+3.6%/yr | +3.6%/yr | 125.01.1× | 51% | 394,700 in 2030+5.7%/yr |
| Skin substitutes & wound grafts | 193 | 48,756+22%/yr | +22%/yr | 13.21.3× | 77% | 79,300 in 2030+8.4%/yr |
| Bone graft & orthobiologics | 52 | 1,980−11%/yr | −11%/yr | 0.91.4× | 3% | 1,960 in 2030−0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 464 | 34,513−0.2%/yr | −0.2%/yr | 15.21.1× | 78% | 40,900 in 2030+2.9%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 60 | 4,698+15%/yr | +15%/yr | 2.01.6× | 72% | 9,310 in 2030+12%/yr |
| Spinal cord & DRG stimulation | 99 | 3,368+0.4%/yr | +0.4%/yr | 1.41.8× | 71% | 4,030 in 2030+3.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 220 | 22,416+0.2%/yr | +0.2%/yr | 9.91.9× | 98% | 30,300 in 2030+5.1%/yr |
| Peripheral arterial intervention | 128 | 16,813−7.6%/yr | −7.6%/yr | 7.41.2× | 58% | 19,600 in 2030+2.6%/yr |
| Dialysis access | 153 | 14,652−16%/yr | −16%/yr | 7.11.4× | 71% | 14,800 in 2030+0.2%/yr |
| Thrombectomy, IVC filters & venous stents | 30 | 4,117+1.6%/yr | +1.6%/yr | 1.91.1× | 17% | 6,020 in 2030+6.5%/yr |
| Carotid revascularization | 54 | 3,080−4.9%/yr | −4.9%/yr | 1.41.1× | 0% | 3,370 in 2030+1.5%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 1,065−5.8%/yr | −5.8%/yr | 0.51.1× | 0% | 1,150 in 2030+1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 166 | 12,981−3%/yr | −3%/yr | 6.41.0× | 6% | 14,900 in 2030+2.3%/yr |
| Cholecystectomy & appendectomy | 216 | 9,832−5.4%/yr | −5.4%/yr | 4.71.0× | 4% | 10,900 in 2030+1.7%/yr |
| Colorectal resection | 15 | 3,636−5.1%/yr | −5.1%/yr | 1.71.0× | 0% | 3,880 in 2030+1.1%/yr |
| Antireflux & hiatal hernia surgery | 40 | 2,078−1.9%/yr | −1.9%/yr | 1.01.3× | 0% | 2,490 in 2030+3%/yr |
| Breast reconstruction | 6 | 1,208−7.1%/yr | −7.1%/yr | 0.61.2× | 6% | 1,830 in 2030+7.1%/yr |
| Bariatric surgery | 0 | 508−19%/yr | −19%/yr | 0.21.3× | 0% | 360 in 2030−5.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 150 | 9,762−6.5%/yr | −6.5%/yr | 4.50.9× | 41% | 9,710 in 2030−0.1%/yr |
| Kidney stone management | 182 | 9,000−1.4%/yr | −1.4%/yr | 4.20.8× | 17% | 11,000 in 2030+3.4%/yr |
| Incontinence, prolapse & sacral neuromodulation | 85 | 6,023−0.4%/yr | −0.4%/yr | 2.81.1× | 24% | 8,340 in 2030+5.6%/yr |
| Hysterectomy, hysteroscopy & ablation | 48 | 4,624−1.2%/yr | −1.2%/yr | 2.40.9× | 16% | 5,220 in 2030+2.1%/yr |
| Prostatectomy & nephrectomy | 41 | 2,635−0.3%/yr | −0.3%/yr | 1.31.1× | 0% | 3,600 in 2030+5.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 145 | 15,144−1.2%/yr | −1.2%/yr | 7.11.5× | 92% | 18,900 in 2030+3.8%/yr |
| Ear tubes & middle ear surgery | 2 | 785−4.7%/yr | −4.7%/yr | 0.41.1× | 37% | 690 in 2030−2.1%/yr |
| Sleep apnea & airway implants | 12 | 595+24%/yr | +24%/yr | 0.31.2× | 14% | 630 in 2030+0.9%/yr |
| Cochlear implants | 9 | 288+1.6%/yr | +1.6%/yr | 0.10.8× | 13% | 330 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 203 | 11,818−2.4%/yr | −2.4%/yr | 5.90.8× | 24% | 13,700 in 2030+2.5%/yr |
| Tumor & fibroid embolization | 20 | 1,239+2.9%/yr | +2.9%/yr | 0.61.0× | 63% | 3,140 in 2030+17%/yr |
| Tumor ablation | 6 | 772−0.3%/yr | −0.3%/yr | 0.41.2× | 0% | 1,010 in 2030+4.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 452 | 65,364+17%/yr | +17%/yr | 29.81.1× | 92% | 129,200 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 220 | 11,944−3.2%/yr | −3.2%/yr | 5.81.0× | 7% | 12,500 in 2030+0.7%/yr |
| EP ablation | 177 | 10,931+7.5%/yr | +7.5%/yr | 4.21.2× | 0% | 20,900 in 2030+11%/yr |
| LAA occlusion & loop recorders | 217 | 9,542+12%/yr | +12%/yr | 3.81.1× | 18% | 18,100 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 422 | 17,591−6%/yr | −6%/yr | 6.61.1× | 5% | 20,600 in 2030+2.7%/yr |
| Structural heart (TAVR, TEER) | 191 | 3,813+6.2%/yr | +6.2%/yr | 1.50.9× | 0% | 6,400 in 2030+9%/yr |
| Mechanical circulatory support | 2 | 1,476−3.6%/yr | −3.6%/yr | 0.71.3× | 0% | 2,210 in 2030+6.9%/yr |
| PFO & septal closure | 1 | 171−2.9%/yr | −2.9%/yr | 0.11.0× | 0% | 210 in 2030+3.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 28 | 1,099+13%/yr | +13%/yr | 0.51.2× | 0% | 2,130 in 2030+12%/yr |
| DBS & VNS | 18 | 941−0.6%/yr | −0.6%/yr | 0.41.4× | 2% | 1,460 in 2030+7.6%/yr |
| Stroke thrombectomy | 25 | 822−0.1%/yr | −0.1%/yr | 0.40.9× | 0% | 1,230 in 2030+6.9%/yr |
| CSF shunts | 2 | 476−4.6%/yr | −4.6%/yr | 0.21.2× | 0% | 540 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 638 | 117,786−2.6%/yr | −2.6%/yr | 53.60.9× | 88% | 129,100 in 2030+1.5%/yr |
| Vitreoretinal surgery | 83 | 6,824−3.6%/yr | −3.6%/yr | 3.21.3× | 80% | 7,210 in 2030+0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 1,233 | 247,310−2.7%/yr | −2.7%/yr | 119.71.0× | 52% | 265,400 in 2030+1.2%/yr |
| ERCP & endoscopic ultrasound | 130 | 7,585−0.2%/yr | −0.2%/yr | 3.61.1× | 6% | 10,200 in 2030+5.1%/yr |
| Bronchoscopy & lung nodule | 98 | 6,069+1.9%/yr | +1.9%/yr | 2.90.8× | 0% | 9,990 in 2030+8.7%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.